You are currently browsing the archives for 14 August 2016.
Displaying 1 entry.

The CHMP has his opinion after examining safety and efficacy data from four clinical trials in 1.

The CHMP has his opinion after examining safety and efficacy data from four clinical trials in 1,500 patients with BPH, including a study of BPH and ED. In addition, data on the safety of the approved indication for the treatment of erectile dysfunction in Lilly were included submissions. In BPH and ED study, Cialis 5 mg once a day use, significantly improved scores on the International Prostate Symptom Score , a questionnaire evaluating, symptoms of BPH and the International Index of Erectile Function – Erectile Function A questionnaire on sexual function..

Approval of Cialis for the treatment of signs and symptoms of benign prostatic hyperplasiatadalafil for the for the treatment of erectile dysfunction in the EU in 2002. Cialis once a day application is approved for the treatment of erectile dysfunction in the EU in 2007.